View Author
scopus: 6602862736

Panaccione, R.

( R. Panaccione)


remission patient mucosal healing disease mucosal healing bowel bowel preservation trial treatment coliti fliximab therapy preservation finition score index activity endoscopic outcome study expert panel consensus panel expert abbott flammation gastroenterology flammatory bowel disease endoscopy symptom crohn guideline surgery result practice survey sandborn wj disease activity stool abbott laboratories physician gastroenterol stool frequency flammatory aliment pharmacol consultant hospitalization table round indices histological factor delphi certolizumab pegol merck assessment tnf antagonists board member speaker pharmacol frequency member relapse value aliment rutgeerts p response sandborn maintenance review antagonist uc-dai research funding steering committee rectal histopathology impact meeting appearance




2 Most Recent Publications

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report (Article)
Feagan, B.G. Lémann, M. Silverberg, M. Sorrentino, D. Woude, C.J. van der Vermeire, S. Rutgeerts, P. Befrits, R. Connell, W. D'Haens, G. Ghosh, S. Michetti, P. Ochsenkühn, T. Panaccione, R. Schreiber, S.
2012-01-01
Review article: Defining remission in ulcerative colitis (Article)
Travis, S.P.L. Higgins, P.D.R. Kamm, M.A. D'Haens, G. Orchard, T. Woude, C.J. van der Panaccione, R. Bitton, A. O'Morain, C. Panés, J. Sturm, A. Reinisch, W.
2011-07-01